$REPL
stock+ Make pickLast price
$20.69
Today
▲ 0.19%
Open
$20.80
Day range
$20.21 – $21.15
Volume
3.1M
52-wk range
$1.50 – $21.26
where the room's targets sit vs price
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2 | Dhingra KapilDirector | Exercise | +43.2K | $1.75 | $75.5K |
| Nov 2 | Dhingra KapilDirector | Sell | −21.5K | $19.00 | $409K |
| Aug 20 | Astley-Sparke PhilipDirector | Gift | −50.0K | $0.00 | $0 |
| Aug 17 | Hill Emily LuisaChief Financial Officer | Sell | −9.3K | $14.28 | $132K |
| Aug 10 | Patel SushilDirector · Chief Executive Officer | Sell | −39.3K | $12.97 | $510K |
| Aug 10 | Hill Emily LuisaChief Financial Officer | Sell | −11.4K | $12.97 | $148K |
| Aug 10 | Xynos KonstantinosChief Medical Officer | Sell | −11.4K | $12.97 | $148K |
| Aug 10 | Schwendenman AndrewChief Accounting Officer | Sell | −7.6K | $12.97 | $99.0K |
| Jun 1 | Sarchi ChristopherChief Commercial Officer | Sell | −12.0K | $9.24 | $111K |
| May 18 | Xynos KonstantinosChief Medical Officer | Sell | −14.0K | $5.08 | $71.2K |
source: SEC EDGAR (Form 4 / 13D / 13G) · free
13D/13G = beneficial owners above 5%. A full institutional holdings table (13F) needs a quarterly bulk-ingest of every manager's filing — also free, planned next.